A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
University of California, San Francisco
University of California, San Francisco
Samus Therapeutics, Inc.
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
Duke University
Duke University
City of Hope Medical Center
Vanderbilt University
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Hospital Medical Center, Cincinnati
Case Comprehensive Cancer Center